Meta-analysis of 74,046 individuals identifies 11 new susceptibility loci for Alzheimer's disease JC Lambert, CA Ibrahim-Verbaas, D Harold, AC Naj, R Sims, ... Nature genetics 45 (12), 1452-1458, 2013 | 4611 | 2013 |
Genome-wide association study identifies variants at CLU and PICALM associated with Alzheimer's disease D Harold, R Abraham, P Hollingworth, R Sims, A Gerrish, ML Hamshere, ... Nature genetics 41 (10), 1088-1093, 2009 | 3416 | 2009 |
Genetic meta-analysis of diagnosed Alzheimer’s disease identifies new risk loci and implicates Aβ, tau, immunity and lipid processing BW Kunkle, B Grenier-Boley, R Sims, JC Bis, V Damotte, AC Naj, ... Nature genetics 51 (3), 414-430, 2019 | 2486 | 2019 |
Common variants at ABCA7, MS4A6A/MS4A4E, EPHA1, CD33 and CD2AP are associated with Alzheimer's disease P Hollingworth, D Harold, R Sims, A Gerrish, JC Lambert, ... Nature genetics 43 (5), 429-435, 2011 | 2257 | 2011 |
Prevalence of cerebral amyloid pathology in persons without dementia: a meta-analysis WJ Jansen, R Ossenkoppele, DL Knol, BM Tijms, P Scheltens, ... Jama 313 (19), 1924-1938, 2015 | 1635 | 2015 |
CSF biomarkers and incipient Alzheimer disease in patients with mild cognitive impairment N Mattsson, H Zetterberg, O Hansson, N Andreasen, L Parnetti, ... Jama 302 (4), 385-393, 2009 | 1467 | 2009 |
Analysis of shared heritability in common disorders of the brain Brainstorm Consortium, V Anttila, B Bulik-Sullivan, HK Finucane, ... Science 360 (6395), eaap8757, 2018 | 1460 | 2018 |
New insights into the genetic etiology of Alzheimer’s disease and related dementias C Bellenguez, F Küçükali, IE Jansen, L Kleineidam, S Moreno-Grau, ... Nature genetics 54 (4), 412-436, 2022 | 1363 | 2022 |
Rivastigmine for Alzheimer's disease JS Birks, JG Evans Cochrane Database of systematic reviews, 2015 | 1153 | 2015 |
Rare coding variants in PLCG2, ABI3, and TREM2 implicate microglial-mediated innate immunity in Alzheimer's disease R Sims, SJ Van Der Lee, AC Naj, C Bellenguez, N Badarinarayan, ... Nature genetics 49 (9), 1373-1384, 2017 | 964 | 2017 |
Prevalence and prognostic value of CSF markers of Alzheimer's disease pathology in patients with subjective cognitive impairment or mild cognitive impairment in the DESCRIPA … PJ Visser, F Verhey, DL Knol, P Scheltens, LO Wahlund, Y Freund-Levi, ... The Lancet Neurology 8 (7), 619-627, 2009 | 736 | 2009 |
Mild cognitive impairment and deficits in instrumental activities of daily living: a systematic review K Jekel, M Damian, C Wattmo, L Hausner, R Bullock, PJ Connelly, ... Alzheimer's research & therapy 7, 1-20, 2015 | 665 | 2015 |
Memantine for patients with Parkinson's disease dementia or dementia with Lewy bodies: a randomised, double-blind, placebo-controlled trial M Emre, M Tsolaki, U Bonuccelli, A Destée, E Tolosa, A Kutzelnigg, ... The Lancet Neurology 9 (10), 969-977, 2010 | 535 | 2010 |
Neuropsychiatric syndromes in dementia: results from the European Alzheimer Disease Consortium: part I P Aalten, FRJ Verhey, M Boziki, R Bullock, EJ Byrne, V Camus, M Caputo, ... Dementia and geriatric cognitive disorders 24 (6), 457-463, 2007 | 510 | 2007 |
Association of plasma clusterin concentration with severity, pathology, and progression in Alzheimer disease M Thambisetty, A Simmons, L Velayudhan, A Hye, J Campbell, Y Zhang, ... Archives of general psychiatry 67 (7), 739-748, 2010 | 499 | 2010 |
Duration of preclinical, prodromal, and dementia stages of Alzheimer's disease in relation to age, sex, and APOE genotype L Vermunt, SAM Sikkes, A Van Den Hout, R Handels, I Bos, ... Alzheimer's & Dementia 15 (7), 888-898, 2019 | 493 | 2019 |
The validation of the short form of the Geriatric Depression Scale (GDS) in Greece KN Fountoulakis, M Tsolaki, A Iacovides, J Yesavage, R O’Hara, A Kazis, ... Aging Clinical and Experimental Research 11, 367-372, 1999 | 460 | 1999 |
Common brain disorders are associated with heritable patterns of apparent aging of the brain T Kaufmann, D van der Meer, NT Doan, E Schwarz, MJ Lund, I Agartz, ... Nature neuroscience 22 (10), 1617-1623, 2019 | 442 | 2019 |
Prevalence and prognosis of Alzheimer’s disease at the mild cognitive impairment stage SJB Vos, F Verhey, L Frölich, J Kornhuber, J Wiltfang, W Maier, O Peters, ... Brain 138 (5), 1327-1338, 2015 | 404 | 2015 |
Subjective cognitive decline and rates of incident Alzheimer's disease and non–Alzheimer's disease dementia RER Slot, SAM Sikkes, J Berkhof, H Brodaty, R Buckley, E Cavedo, ... Alzheimer's & Dementia 15 (3), 465-476, 2019 | 375 | 2019 |